Scarica l'app Stockscreener
13.65
1.09%
-0.1699
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WVE Giù?
Forum
Previsione
Wave Life Sciences Ltd Borsa (WVE) Ultime notizie
Volatility Watch: Can Wave Life Sciences Ltd beat the S P 500Dollar Strength & Step-by-Step Trade Execution Guides - baoquankhu1.vn
WAVE Life Sciences Ltd. $WVE Shares Sold by Emerald Advisers LLC - MarketBeat
WAVE Life Sciences Ltd. (NASDAQ:WVE) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
US Stocks Recap: Will Wave Life Sciences Ltd. outperform small cap indexes2025 AllTime Highs & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Leader with 133.86% Potential Upside - DirectorsTalk Interviews
Should Wave’s New Obesity Data and INHBE/ALK7 Focus Require Action From Wave Life Sciences (WVE) Investors? - Yahoo Finance
A Look At Wave Life Sciences (WVE) Valuation After WVE-007 Obesity Data And Development Update - simplywall.st
First Week of March 20th Options Trading For Wave Life Sciences (WVE) - Nasdaq
How Wave Life Sciences Ltd. (WVE) Affects Rotational Strategy Timing - Stock Traders Daily
Wave Life Sciences (WVE) Deepens Obesity Bet With WVE-007 Focus – Is Its Platform Strategy Evolving? - simplywall.st
WAVE Life Sciences (NASDAQ:WVE) Shares Up 6.8%Time to Buy? - MarketBeat
Truist Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating - 富途牛牛
Wave Life Sciences (WVE) Receives a Buy from Raymond James - The Globe and Mail
Bull Bear: Will Wave Life Sciences Ltd stock recover faster than peersJuly 2025 Setups & Safe Entry Trade Signal Reports - moha.gov.vn
Wave Life Sciences Ltd. (WVE) Stock Analysis: A Biotech Gem With 129% Upside Potential - DirectorsTalk Interviews
Wave Life Sciences to expand obesity drug trials in 2026 By Investing.com - Investing.com Nigeria
Wave Life Sciences to expand obesity drug trials in 2026 - Investing.com
Wave Life Sciences sets 2026 strategy, highlights obesity program - TipRanks
Wave Life Sciences Announces Plans for Phase 2a Trial of WVE-007 for Obesity and Advances RNA Editing Portfolio in 2026 - Quiver Quantitative
Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio - The Manila Times
An experimental RNA obesity treatment could allow once‑yearly dosing - Stock Titan
Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 for Obesity and Rapidly Advancing RNA Editing Portfolio - Investing News Network
WAVE Life Sciences (NASDAQ:WVE) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next - TechStock²
Will Wave Life Sciences Ltd. stock maintain growth storyJuly 2025 Decliners & Expert Verified Movement Alerts - ulpravda.ru
Wave Life Sciences Ltd. (NASDAQ:WVE) May Have Run Too Fast Too Soon With Recent 30% Price Plummet - 富途牛牛
WAVE Life Sciences (NASDAQ:WVE) Shares Down 4.5%Here's Why - MarketBeat
Wave Life Sciences (WVE) stock slides 6% even as biotech ETFs rise — what’s driving it now - TechStock²
Wave Life Sciences (WVE) emerges as obesity treatment contender, Oppenheimer boosts price target - MSN
Wave Life Sciences upgraded at RBC following data for obesity asset WVE-007 - MSN
Is Wave Life Sciences Ltd. (1U5) stock protected from inflationEarnings Trend Report & Real-Time Market Sentiment Reports - ulpravda.ru
Aug Patterns: Will Wave Life Sciences Ltd. stock outperform tech sector in 2025CPI Data & Daily Entry Point Trade Alerts - ulpravda.ru
How Wave Life Sciences Ltd. (1U5) stock benefits from digital adoptionEarnings Summary Report & Safe Entry Momentum Stock Tips - ulpravda.ru
Quarterly Risk: Is Wave Life Sciences Ltd. stock dividend yield sustainableMarket Growth Summary & Safe Capital Allocation Plans - ulpravda.ru
What technical charts say about Wave Life Sciences Ltd. stock2025 Momentum Check & Accurate Trade Setup Notifications - ulpravda.ru
Will Wave Life Sciences Ltd. stock outperform tech sector in 2025July 2025 Trade Ideas & Step-by-Step Swing Trade Plans - ulpravda.ru
Wave Life Sciences (WVE) Valuation In Focus As Obesity Data, Equity Raise And Conference Updates Draw Attention - simplywall.st
Is Wave Life Sciences Ltd. stock attractive for income investorsPrice Channel Trading & Unlock Patterns Humans Can’t See - ulpravda.ru
Why Wave Life Sciences Ltd. stock is rated strong buyEx-Dividend Date Alerts & Use Smart Algorithms to Pick Better Stocks - ulpravda.ru
Raymond James raises WAVE Life Sciences stock price target to $26 By Investing.com - Investing.com South Africa
Raymond James raises WAVE Life Sciences stock price target to $26 - Investing.com India
Arrowhead siRNA data in obesity mark POC for adipose delivery - BioCentury
Is Wave Life Sciences’ (WVE) Obesity Bet and Extended Cash Runway Quietly Redefining Its Risk‑Reward Profile? - simplywall.st
HC Wainwright maintains a buy rating on Wave Life Sciences Ltd. (WVE) - MSN
Growth or Bubble? Decoding Wave Life Sciences’ Stock Rise - StocksToTrade
Wave Life Sciences stock gains after Arrowhead data supports INHBE mechanism - Investing.com UK
Wave Life Sciences (WVE) Sees Stock Rise Amid Positive Weight Lo - GuruFocus
Wave Life Sciences stock jumps 17% as obesity gene-silencing race heats up - TechStock²
WAVE Life Sciences (NASDAQ:WVE) Shares Gap UpWhat's Next? - MarketBeat
Wave Life Sciences (WVE) Rises Over 18% Following Market Activit - GuruFocus
Is Wave Life Sciences’ Stock a Hidden Gem? - timothysykes.com
Assessing Wave Life Sciences (WVE) Valuation After A Sharp Share Price Rebound - Yahoo Finance
Wave Life Sciences Ltd. (WVE) Stock Analysis: A Biotech Innovator with Over 110% Potential Upside - DirectorsTalk Interviews
WAVE Life Sciences (NASDAQ:WVE) Insider Sells $150,281.25 in Stock - MarketBeat
Wave Life Sciences stock drops 8% as JPM Healthcare Conference looms; obesity data in focus - TechStock²
Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Wave Life Sciences (WVE) stock slides 6% — what traders are watching next - TechStock²
Wave Life Sciences stock drops 6% as WVE traders size up next obesity data - TechStock²
WAVE Life Sciences (NASDAQ:WVE) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
3.19%
2.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):